#Vyloy
A year ago, #Astellas was celebrating the first-in-class approval of its #claudin 18.2-targeting cancer drug Vyloy for gastric cancers. Now, a bid to expand its label into #pancreaticcancer has hit the buffers.

pharmaphorum.com/news/astella...
October 14, 2025 at 8:56 AM Everybody can reply
アステラス製薬によるガニメド(Ganymed Pharmaceuticals)買収の話も出てきて、調べてみると€422百万の一時金+最大€860百万の成果連動支払で、その後、胃がん治療薬ビロイ(VYLOY, ゾルベツキシマブ)は商品化に成功し売り上げが拡大してるけど、買収額が巨額過ぎたのか、24年度第3四半期決算で株式減損処理で606億円の特別損失を計上。
www.mixonline.jp/tabid55.html...
mRNAワクチンの衝撃 ―コロナ制圧と医療の未来―
ファイザー社と組み、11カ月という常識外のスピードで世界初の新型コロナワクチンの開発に成功したドイツ・ビオンテック社。画期的なmRNA技術で一躍注目を集めるバイオ企業の創業者/研究者夫妻に密着、熾烈な…
www.hayakawa-online.co.jp
September 29, 2025 at 11:58 PM Everybody can reply
アステラス製薬によるガニメド(Ganymed Pharmaceuticals)買収の話も出てきて、調べてみると€422百万の一時金+最大€860百万の成果連動支払で、その後、胃がん治療薬ビロイ(VYLOY, ゾルベツキシマブ)は商品化に成功し売り上げが拡大してるけど、買収額が巨額過ぎたのか、24年度第3四半期決算で株式減損処理で606億円の特別損失を計上。
September 30, 2025 at 12:14 AM Everybody can reply
‘Have we no shame?’ Federal judge declares NIH grant terminations ‘void and illegal.’

This is a strong affirmation that gov't cannot arbitrarily cut research funding based on political or ideological criteria, and that sci research must be allowed to proceed based on its merit.

archive.ph/vyLOy
archive.ph
June 16, 2025 at 8:55 PM Everybody can reply
6 likes
«Astellas получает одобрение Европейской комиссии для VYLOY в борьбе с.advance стадиями рака желудка»

https://kripta.biz/posts/198E0B2C-018C-41F6-89F7-302C27E74DBC
January 5, 2025 at 7:22 AM Everybody can reply
Astellas Obtiene Aprobación de la Comisión Europea para VYLOY: Un Avance Esperanzador en el Tratamiento del Cáncer Gástrico Avanzado

https://eldinero.lat/posts/9A6B536D-0CBD-4082-815A-ED276B4F4131
January 5, 2025 at 7:22 AM Everybody can reply
阿斯特拉斯获得欧洲委员会批准,VYLOY作为晚期胃癌新疗法问世

https://qian.cx/posts/7C41D4C7-5DA4-4B1D-ADDE-5955FA082F28
January 5, 2025 at 7:22 AM Everybody can reply
[FiercePharma]Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy - FiercePharma After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer med Vyloy. | Astellas' Vyloy won an FDA approval to treat gastric...
October 20, 2024 at 5:15 PM Everybody can reply
Japanese pharmaco Astellas's gastric cancer drug, brand name Vyloy has been approved by the UK's health regulator. EU approval likely in October this year. It was approved in Japan in March 2024.
www.reuters.com/business/hea...
Astellas' gastric cancer therapy gets UK regulator's nod
Britain's health regulator said on Wednesday it has approved Japan-based Astellas Pharma's therapy to treat a type of gastric cancer.
www.reuters.com
August 16, 2024 at 9:24 AM Everybody can reply
1 likes